Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Weekly
Analytics
American chemical industry news
9 February 2026
Symrise Antitrust Investigation Closed by U.S. DoJ
The U.S. DoJ found no unlawful practices. Symrise maintains its commitment to ethical business and anticipates similar outcomes in other investigations.
9 February 2026
Novo Nordisk Sues Hims & Hers Over Unapproved Semaglutide Products
Novo Nordisk seeks to stop Hims from selling unapproved semaglutide, citing patient safety risks and patent infringement.
9 February 2026
Lilly Acquires Orna Therapeutics for Cell Therapy Advancements
Lilly acquires Orna to enhance genetic medicine and in vivo cell engineering, focusing on autoimmune diseases with circular RNA and lipid nanoparticle technology.
9 February 2026
TotalEnergies to Supply 1 GW Solar Power to Google's Texas Data Centers
TotalEnergies signs PPAs to deliver 1 GW solar power for Google's Texas data centers, creating jobs and boosting local tax revenue. Construction starts Q2 2026.
7 February 2026
Johnson & Johnson Shares OMNY-AF Pilot Study Results at AF Symposium 2026
OMNY-AF study shows 100% procedural success, 90% effectiveness at 12 months. VARIPULSE data highlights low neurovascular events and consistent safety across clinical settings.
7 February 2026
Roche's Fenebrutinib Reduces Disability Progression in PPMS
Fenebrutinib shows 12% risk reduction in disability progression vs. OCREVUS in PPMS, with potential benefits in upper limb function and plans for regulatory submission in 2026.
How does the American chemical industry perform?
Find out with
chemXplore Analytics
Learn more
6 February 2026
BASF's Engenia Herbicide Approved by EPA
EPA approves Engenia herbicide for dicamba-tolerant soybeans and cotton, offering farmers a tool against resistant weeds. BASF provides training for proper application.
6 February 2026
Covestro, Fertiglobe, TA’ZIZ Explore Ammonia Collaboration
The MoU explores ammonia supply and infrastructure, focusing on low-carbon production and long-term opportunities in China, the US, Europe, and the UAE.
6 February 2026
Ørsted Reports DKK 25.1 Billion Earnings in 2025
Ørsted strengthened its capital structure, completed divestments, and expanded offshore wind capacity, achieving a net profit of DKK 3.2 billion in 2025.
5 February 2026
Chevron Announces Leadership Changes
Chevron announces retirements and new appointments in senior leadership roles, including Corporate Business Development, Supply & Trading, and Shale & Tight divisions.
4 February 2026
LOTTE Chemical Plans 2026 Expansion in High-Performance Materials and Eco-Friendly Energy
Recorded KRW 18,483B revenue, KRW 943.6B loss in 2025. Focus on reducing commodity petrochemicals, expanding high-value materials, and boosting eco-friendly energy capacity.
4 February 2026
Novo Nordisk Launches Ozempic® Pill in US by Q2 2026
FDA approves Ozempic® tablets for type 2 diabetes, offering enhanced bioavailability. Launch set for Q2 2026.
4 February 2026
Lilly Q4 2025 Financial Results and 2026 Outlook
Q4 revenue rose 43% to $19.3B, EPS up 51%. FDA approved Kwikpen, expanded Jaypirca use. 2026 revenue guidance: $80B-$83B, EPS: $33.50-$35.00.
4 February 2026
ARLANXEO Opens New HNBR Plant in China
The new plant in Changzhou boosts HNBR production for strategic sectors, enhances local R&D, and supports sustainability with advanced technology and energy efficiency.
4 February 2026
UPM 2025 Financials: Strong Cash Flow, Strategic Moves
Q4 sales and EBIT down, but cash flow strong. Strategic actions include joint ventures, investments, and closures. Sustainability recognized with top ratings.
3 February 2026
Novo Nordisk Reports 6% Sales Growth in DKK, 10% at CER for 2025
Operating profit fell 1% in DKK, rose 6% at CER. US FDA approved oral GLP-1 for obesity. 2026 sales growth expected to decline due to pricing and competition. New treatments in pipeline.
3 February 2026
Novo Nordisk 2025 Financial Report
Sales rose 10% at CER, operating profit up 6%. US FDA approved oral GLP-1. 2026 outlook: sales/profit growth -5% to -13% at CER. New share repurchase program announced.
3 February 2026
SABIC Introduces Biocompatible Materials and Fluoropolymer Alternatives at MD&M West
Showcasing medical-grade thermoplastics, SABIC addresses performance and regulatory challenges, offering solutions for drug delivery, patient testing, and surgical applications.
3 February 2026
Merck Announces Q4 and Full-Year 2025 Financial Results, Highlights Pipeline Progress
Strong oncology and animal health sales, positive trial results, and strategic acquisitions drive growth. 2026 outlook projects sales up to $67B, with EPS impacted by acquisition charges.
3 February 2026
Elkem's MIRASIL™ N‑DML 15 Wins SEAL Environmental Initiative Award
MIRASIL™ N‑DML 15, a sustainable silicone blend, offers high performance with reduced carbon footprint, using renewable sunflower-based carrier, enhancing Elkem's eco-friendly product line.
3 February 2026
Xfloat and BASF Enhance Floating Solar Durability
The collaboration integrates advanced stabilizers to enhance FPV systems' durability, reducing costs and meeting safety standards for deployment in sensitive environments.
3 February 2026
WuXi Biologics and Vertex License Agreement for T-cell Engager
Vertex gains global rights to develop a trispecific T-cell Engager for autoimmune diseases, with WuXi Biologics providing research and development services.
3 February 2026
Arkema and Senior Collaborate on Next-Gen Battery Materials
The collaboration aims to enhance battery performance, safety, and efficiency through advanced materials and separator technologies, supporting innovation in the global battery market.
2 February 2026
Court Allows Ørsted's Sunrise Wind Project to Resume Construction
A U.S. court lifted a suspension, allowing the Sunrise Wind Project to restart construction, prioritizing safety and aiming to provide reliable power to New York.
2 February 2026
Equinor Sells Argentina Onshore Assets to Vista Energy
Equinor divests its Vaca Muerta onshore assets for $1.1B, enhancing financial flexibility and focusing on offshore opportunities.
30 January 2026
Hycamite Hosts Finnish Officials, Highlights Critical Minerals Role
Officials toured Hycamite's facility, learning about its methane-splitting tech for low-carbon hydrogen and graphite, supporting EU supply-chain goals and reducing import dependency.
30 January 2026
Lilly to Build $3.5B Manufacturing Facility in Pennsylvania
The new facility will create 2,800 jobs, produce weight-loss medicines, and boost the local economy with advanced technologies and partnerships in education and workforce development.
30 January 2026
Chevron Q4 2025 Financial Results
Earnings at $2.8B, adjusted $3.0B. Cash flow $10.8B, free cash $4.2B. Production up 12% globally, 16% U.S. Reserve replacement 158%. Dividend up 4% to $1.78/share.
29 January 2026
Dow unveils Transform to Outperform for enhanced productivity and growth
Dow aims for $2B Op. EBITDA boost by simplifying operations, cutting costs, and modernizing customer service, with $1.1-1.5B in one-time costs, including severance for 4,500 roles.
29 January 2026
Lilly Addresses AHA Concerns on 340B Program Changes
Lilly extends claims data collection to curb 340B program abuse, countering AHA's claims of illegality and burden, aiming for transparency and patient benefit.
Next →
